Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

Todd Neale

July 24, 2025

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

L.A. McKeown

July 24, 2025

News Daily News

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Michael O'Riordan

July 18, 2025

News Daily News

Clinicians Take Heed—High BP Merits Quick Action, Data Suggest

Caitlin E. Cox

July 17, 2025

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

News Opinion CV Team Dispatch

June 2025 Dispatch for the CV Team

L.A. McKeown

June 26, 2025

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Daily News

Majority of US Adults Have High Long-term Risk of CVD: NHANES

Michael O'Riordan

June 13, 2025

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

News Conference News ESOC 2025

Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors

Todd Neale

June 02, 2025

News Conference News EuroPCR 2025

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Michael O'Riordan

May 29, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

News Daily News

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Yael L. Maxwell

April 29, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Daily News

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Michael O'Riordan

April 09, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Opinion CV Team Dispatch

February 2025 Dispatch for the CV Team

L.A. McKeown

February 01, 2025

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown

January 31, 2025

Advertisement

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

July 2025 Dispatch for the CV Team

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Clinicians Take Heed—High BP Merits Quick Action, Data Suggest

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

June 2025 Dispatch for the CV Team

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Majority of US Adults Have High Long-term Risk of CVD: NHANES

FDA Approves Triple Therapy Polypill for High Blood Pressure

Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

May 2025 Dispatch for the CV Team

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

April 2025 Dispatch for the CV Team

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

March 2025 Dispatch for the CV Team

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

February 2025 Dispatch for the CV Team

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content